Cancer Recurrence Clinical Trials

4 recruiting

Cancer Recurrence Trials at a Glance

13 actively recruiting trials for cancer recurrence are listed on ClinicalTrialsFinder across 6 cities in 8 countries. The largest study group is Not Applicable with 9 trials, with the heaviest enrollment activity in Leiden, Hong Kong, and Aarhus. Lead sponsors running cancer recurrence studies include The University of Hong Kong, CHU de Quebec-Universite Laval, and Brigitta Rasmussen Villumsen.

Browse cancer recurrence trials by phase

Treatments under study

About Cancer Recurrence Clinical Trials

Looking for clinical trials for Cancer Recurrence? There are currently 4 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Cancer Recurrence trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Cancer Recurrence clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 113 of 13 trials

Recruiting

Patient-partnered Research in Investigating Fear of Cancer Recurrence in Kidney Cancer

Renal Cell Carcinoma (Kidney Cancer)Fear of Cancer Recurrence
Brigitta Rasmussen Villumsen105 enrolled3 locationsNCT07234656
Recruiting
Not Applicable

Cognitive Behavioral Therapy for Fear of Cancer Recurrence in Women With BRCA1/2 Gene

BRCA2 MutationFear of Cancer RecurrenceBreast Cancer Susceptibility Gene (BRCA1) Mutation
CHU de Quebec-Universite Laval250 enrolled1 locationNCT06817694
Recruiting
Not Applicable

Optimal Mammography View Sequencing in Women With a History of Breast Cancer Undergoing Surveillance Mammography

Breast CancerBreast Cancer RecurrencePost Treatment Surveillance
Royal College of Surgeons, Ireland400 enrolled1 locationNCT07443579
Recruiting

Multiplex Mutation Detection Using Mass Spectrometry in Bladder Cancer

Bladder CancerBladder Cancer RecurrenceAdjuvant Therapy for Bladder Cancer+1 more
Zhilong Dong400 enrolled1 locationNCT07424560
Recruiting
Not Applicable

Parental Support Intervention in an Advanced Oncological Context

Metastatic CancerCommunicationCancer Recurrence+3 more
Université Libre de Bruxelles120 enrolled1 locationNCT07341815
Recruiting
Not Applicable

E-intervention on Subclinical Fear of Cancer Recurrence

CancerFear of Cancer RecurrencePsychooncology
The University of Hong Kong48 enrolled1 locationNCT06207006
Recruiting
Not Applicable

Adapting The Fear Of Recurrence Therapy (FORT) for Parents and Establishing Acceptability and Feasibility

CancerChildhood Cancer SurvivorsFear of Cancer Recurrence+2 more
University of Ottawa36 enrolled1 locationNCT06872840
Recruiting
Phase 4

Impact of Remimazolam on Prognosis After Bladder Cancer Surgery

SurgeryBladder CancerCancer Recurrence+2 more
Peking University First Hospital1,128 enrolled6 locationsNCT04532606
Recruiting
Not Applicable

Opioid-free Anaesthesia in Breast Cancer Surgery

Breast CancerPain, ChronicPain, Postoperative+3 more
University of Ioannina200 enrolled1 locationNCT06404983
Recruiting
Not Applicable

Implementation and Evaluation of a Fear of Cancer Recurrence Screening, Referral and Management Program

CancerFear of Cancer Recurrence
The University of Hong Kong1,980 enrolled2 locationsNCT06181344
Recruiting
Not Applicable

EMDR for Fear of Cancer Recurrence in Patients with Familial Melanoma: a Waiting List Control Trial

Familial MelanomaFear of Cancer RecurrenceEye Movement Desensitization and Reprocessing+1 more
Leiden University Medical Center30 enrolled2 locationsNCT06767332
Recruiting
Not Applicable

CIFeR - A Clinician-led Intervention to Address Fear of Cancer Recurrence

Fear of Cancer Recurrence
Aarhus University Hospital300 enrolled1 locationNCT06554899
Recruiting
Phase 3

PSMA-PET Guided Hypofractionated Salvage Prostate Bed Radiotherapy

Prostate CancerCancer Recurrence
University Medical Center Groningen538 enrolled13 locationsNCT04642027